Clinical Trials in Houston

Showing 16141-16160 of 17,885 trials

Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

NCT00002725

Phase II trial to study the effectiveness of bryostatin-1 in treating patients with recurrent non-Hodgkin's lymphoma. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.

Lymphoma

National Cancer Institute (NCI)35 participantsStarted Aug 1996

Houston, Texas, United States

COMPLETEDPhase 1< 1 mile

Bexarotene in Preventing Breast Cancer in Women at Genetic Risk

NCT00055991

RATIONALE: Chemoprevention therapy uses certain drugs to try to prevent the development or recurrence of cancer. It is not yet known whether bexarotene is effective in preventing breast cancer. PURPOSE: Randomized clinical trial to study the effectiveness of bexarotene in preventing breast cancer in women who are at genetic risk of developing breast cancer.

Breast Cancer

Baylor Breast Care Center87 participantsStarted Sep 2001

Washington D.C., District of Columbia, United States • Houston, Texas, United States • Houston, Texas, United States +1 more locations

COMPLETEDPhase 2< 1 mile

Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma

NCT00006102

Phase II trial to study the effectiveness of rebeccamycin analogue in treating children who have solid tumors or non-Hodgkin's lymphoma. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.

Brain and Central Nervous System TumorsLymphomaNeuroblastoma+3 more

National Cancer Institute (NCI)200 participantsStarted Jul 2000

Birmingham, Alabama, United States • Mobile, Alabama, United States • Phoenix, Arizona, United States +223 more locations

Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

Bexarotene in Preventing Breast Cancer in Women at Genetic Risk

Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma

Find Trials by Condition in Houston

Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors

O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors

Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia

Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia

Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease

Topotecan in Treating Children With Refractory Leukemia

Tracking of Respiratory-Induced Tumor Motion Using Implanted Fiducials

S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium

Elitek (Rasburicase) Immuno-Monitoring Study

S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer

AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer

Optimize RV Selective Site Pacing Clinical Trial

Sole-Therapy Treatment of Atrial Fibrillation

A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer

Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer

Study Evaluating SKI-606 (Bosutinib) In Subjects With Breast Cancer

Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease